Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial

Åhrén, Bo; B. Hirsch, Irl; R. Pieber, Thomas; Mathieu, Chantal; Gómez‐Peralta, Fernando; Krarup Hansen, Troels; Philotheou, Areti; Birch, Sune; Christiansen, Erik; Jensen, Thomas; B. Buse, John; the ADJUNCT TWO Investigators, for

doi:10.2337/dc16-0690

Public

Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial

Published in Diabetes Care • Aug 4, 2016

Authors:

Bo Åhrén

Irl B. Hirsch

Thomas R. Pieber

Abstract

OBJECTIVE: To investigate the efficacy and safety of liraglutide added to capped insulin doses in subjects with type 1 diabetes. RESEARCH DESIGN AND METHODS: A 26-week, placebo-controlled, double-blind, parallel-group trial enrolling 835 subjects randomized 3:1 receiving once-daily subcutaneous lira...

Subject

Liraglutide

Medicine

Placebo

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!